Suscribirse

Comparing clinical success and procedural difficulty between treatment-naïve and treatment-refractory patients with esophageal motility disorders during peroral endoscopic myotomy - 16/06/23

Doi : 10.1016/j.gie.2023.01.052 
Jagannath Kadiyala, MD 1, Andrew Canakis, MD 2, David Uihwan Lee, MD 2, Pei Xue, MD 3, Gregory H. Fan, BS 4, Raymond E. Kim, MD 2,
1 Department of Medicine, University of Virginia School of Medicine, Charlottesville, VA, USA 
2 Division of Gastroenterology & Hepatology, University of Maryland School of Medicine, Baltimore, MD, USA 
3 Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA 
4 Department of Medicine, Tufts University School of Medicine, Boston, MA, USA 

Reprint requests: Raymond E. Kim, MD, University of Maryland Medical Center, 22 S Greene St, Baltimore, MD 21201.University of Maryland Medical Center22 S Greene StBaltimoreMD21201

Abstract

Background and Aims

Peroral endoscopic myotomy (POEM) can successfully treat patients with achalasia. Prior therapy with Botox (Allergan, Madison, NJ, USA) injections, pneumatic dilation (PD), and/or laparoscopic Heller myotomy (LHM) is believed to increase the difficulty of POEM procedures. We aimed to determine if prior treatment methods were associated with longer procedure times or lower clinical success.

Methods

In this single-center retrospective study, consecutive patients who underwent POEM for achalasia between February 2017 and September 2021 were studied. Collected data were patient demographics, prior treatment, pre- and postprocedure Eckardt score (ES), distensibility indices (DIs), and procedure times. Primary outcomes were clinical success and procedure difficulty.

Results

Of 95 patients (mean age, 55.6 years; 45% women), 25 patients underwent POEM for type I achalasia, 31 for type II achalasia, and 33 for spastic esophageal pathologies. Thirty-three patients (34.7%) were treated for achalasia before POEM with onabotulinumtoxinA injections (n = 18), PD (n = 17), and LHM (n = 3). There were no significant differences in post-treatment ESs or technical success between the 2 groups (P = .98 and P = .66, respectively). Multivariate analysis showed that prior treatment was associated with decreased case time and easier tunneling during POEM.

Conclusions

Prior treatment did not impact the clinical success rate of POEM and led to decreased case times and easier tunneling difficulty, likely because of persistent lower esophageal sphincter changes and differences in diagnostic indications. POEM should be considered for patients with treatment-refractory symptoms as a safe and feasible option. Further large-scale studies are needed to validate our findings.

El texto completo de este artículo está disponible en PDF.

Graphical abstract




El texto completo de este artículo está disponible en PDF.

Abbreviations : aOR, CI, DI, ES, LES, LHM, PD, POEM, PPI, TPL


Esquema


 DISCLOSURE: The following author disclosed financial relationships: R. E. Kim: Consultant for Medtronic, Cook Medical, and Apollo Endosurgery. All other authors disclosed no financial relationships.
 DIVERSITY, EQUITY, AND INCLUSION: We worked to ensure ethnic or other types of diversity in the recruitment of human subjects. One or more of the authors of this paper self-identifies as an under-represented ethnic minority in science. The author list of this paper includes contributors from the location where the research was conducted who participated in the data collection, design, analysis, and/or interpretation of the work.


© 2023  Publicado por Elsevier Masson SAS.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 98 - N° 1

P. 19 - juillet 2023 Regresar al número
Artículo precedente Artículo precedente
  • Cold snare versus cold forceps polypectomy for endoscopic resection of diminutive polyps: meta-analysis of randomized controlled trials
  • Faisal Kamal, Muhammad Ali Khan, Wade Lee-Smith, Sachit Sharma, Ashu Acharya, Umer Farooq, Amit Agarwal, Muhammad Aziz, Justin Chuang, Anand Kumar, Alexander Schlachterman, David Loren, Thomas Kowalski, Douglas Adler
| Artículo siguiente Artículo siguiente
  • Prospective multicenter assessment of the impact of EUS-guided gastroenterostomy on patient quality of life in unresectable malignant gastric outlet obstruction
  • Francisco Javier Garcia-Alonso, Carlos Chavarria, Jose Carlos Subtil, Jose Ramón Aparicio, Victoria Busto Bea, Belén Martinez-Moreno, Juan J. Vila, Vanessa Martín-Álvarez, Laura Sanchez-Delgado, Carlos de la Serna-Higuera, Manuel Perez-Miranda

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

¿Ya suscrito a @@106933@@ revista ?

@@150455@@ Voir plus

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2026 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.